Dr. Lonnie David Alexander, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2000 W. 21st Street, Ste A-1, Clovis, NM 88101 Phone: 575-762-8055 Fax: 575-763-3351 |
Michele Hannagan, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Plains Regional Medical Group, 2200 W 21st St, Clovis, NM 88101 Phone: 575-769-7577 Fax: 575-769-7595 |
Dr. Rob Joseph Kamermans, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2100 N Dr Martin Luther King Jr Blvd, Clovis, NM 88101 Phone: 505-769-7153 Fax: 505-769-7337 |
Dr. Padmaneel B Kanase, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Martin Luther King Jr Blvd, Clovis, NM 88101 Phone: 505-769-7153 Fax: 505-769-7337 |
Dr. Catherine Irene Mcdowell, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1821 Arbor Dr, Clovis, NM 88101 Phone: 505-791-6285 |
Stephen N Luker, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 224 West D.l. Ingram Ave, Bldg 1408, Clovis, NM 88101 Phone: 575-784-7625 |
Kelsi Peabody, FNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 2301 N Mlk Blvd, Clovis, NM 88101 Phone: 575-762-4455 |
Dr. Larry Lowry, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 208 Sandzen Dr, Clovis, NM 88101 Phone: 575-762-6411 |
Constance C Belcher, CFNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2513 Fred Daugherty Ave, Clovis, NM 88101 Phone: 575-760-0160 Fax: 575-762-1676 |
Ali M Ghaffari Sr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 815 West 14th St, Clovis, NM 88101 Phone: 505-762-6492 Fax: 505-762-9981 |
Alex John Lee, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 27 Medical Group, Bldg 1400 208 W Casablanca Cannon Afb, Clovis, NM 88103 Phone: 505-784-6608 Fax: 505-784-6028 |
News Archive
In a new investigational study of VYTORIN, the cholesterol-lowering medicine from Merck, VYTORIN 10/20 mg reduced the incidence of first major vascular events defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure by a highly statistically significant 16.1 percent compared to placebo, Study of Heart and Renal Protection study involved more than 9,000 patients who, on average, had advanced or end-stage chronic kidney disease (CKD)
Liquidia Technologies today announced a collaboration with the PATH Malaria Vaccine Initiative (MVI) to explore the use of the company's PRINT® particle technology to design next generation malaria vaccines. PRINT technology offers unprecedented control of particle size, shape and chemistry in a highly consistent and scalable manufacturing process, and will be used to deliver a protein in combination with immune stimulating molecules.
The American College of Cardiology will host the ACC Latin America Conference in partnership with the Peruvian Society of Cardiology in Lima, Peru, on November 16-17, 2018, bringing together top experts to review and discuss new, relevant cardiovascular science pertinent to the region. This is the first time the conference will be held in South America.
The NovoCyte system with its updated software and firmware provides broader versatility and flexibility with its multi-option optical configuration capabilities.
› Verified 2 days ago